These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38375236)

  • 1. Basic-helix-loop-helix family member e41 suppresses osteoclastogenesis and abnormal bone resorption disease via NFATc1.
    Zhang Y; Li X; Lang J; Li W; Huang D; Sun W; Yang L; Li W; Wang Y; Zhang L
    iScience; 2024 Mar; 27(3):109059. PubMed ID: 38375236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1.
    Zhang Y; Yang M; Zhang S; Yang Z; Zhu Y; Wang Y; Chen Z; Lv X; Huang Z; Xie Y; Cai L
    Cell Biosci; 2022 May; 12(1):70. PubMed ID: 35619122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological inhibition of protein S-palmitoylation suppresses osteoclastogenesis and ameliorates ovariectomy-induced bone loss.
    Ma L; Zhang L; Liao Z; Xiu C; Luo X; Luo N; Zhang L; He G; Chen J
    J Orthop Translat; 2023 Sep; 42():1-14. PubMed ID: 37521493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major vault protein (MVP) negatively regulates osteoclastogenesis via calcineurin-NFATc1 pathway inhibition.
    Yuan L; Zhao N; Wang J; Liu Y; Meng L; Guo S; Wiemer EAC; Chen Q; Mao Y; Ben J; Ma J
    Theranostics; 2021; 11(15):7247-7261. PubMed ID: 34158848
    [No Abstract]   [Full Text] [Related]  

  • 5. RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling.
    Wang J; Xu C; Zhang J; Bao Y; Tang Y; Lv X; Ma B; Wu X; Mao G
    Mol Med; 2023 Apr; 29(1):49. PubMed ID: 37020186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role of helix-loop-helix transcriptional factor Bhlhe40 in osteoclast activation.
    Hirata H; Kamohara A; Murayama M; Nishioka K; Honda H; Urano Y; Soejima H; Oki S; Kukita T; Kawano S; Mawatari M; Kukita A
    J Cell Physiol; 2022 Oct; 237(10):3912-3926. PubMed ID: 35908202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk-JNK through DOK3.
    Zhang Y; Zhang S; Wang Y; Yang Z; Chen Z; Wen N; Yang M; Huang Z; Xie Y; Cai L
    Oxid Med Cell Longev; 2021; 2021():2896674. PubMed ID: 34820053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca
    Cao B; Dai X; Wang W
    J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation.
    Zhuang J; Ning H; Wang M; Zhao W; Jing Y; Liu X; Zu J; Kong P; Wang X; Sun C; Yan J
    Cell Signal; 2021 Nov; 87():110137. PubMed ID: 34469786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
    Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
    Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early growth response 2 negatively modulates osteoclast differentiation through upregulation of Id helix-loop-helix proteins.
    Kim HJ; Hong JM; Yoon KA; Kim N; Cho DW; Choi JY; Lee IK; Kim SY
    Bone; 2012 Oct; 51(4):643-50. PubMed ID: 22842221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA AK077216 promotes RANKL-induced osteoclastogenesis and bone resorption via NFATc1 by inhibition of NIP45.
    Liu C; Cao Z; Bai Y; Dou C; Gong X; Liang M; Dong R; Quan H; Li J; Dai J; Kang F; Zhao C; Dong S
    J Cell Physiol; 2019 Feb; 234(2):1606-1617. PubMed ID: 30132869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL14 represses osteoclast formation to ameliorate osteoporosis via enhancing GPX4 mRNA stability.
    Deng M; Luo J; Cao H; Li Y; Chen L; Liu G
    Environ Toxicol; 2023 Sep; 38(9):2057-2068. PubMed ID: 37195267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells.
    Egusa H; Doi M; Saeki M; Fukuyasu S; Akashi Y; Yokota Y; Yatani H; Kamisaki Y
    Bone; 2011 Aug; 49(2):264-74. PubMed ID: 21504804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water extract of the fruits of Alpinia oxyphylla inhibits osteoclast differentiation and bone loss.
    Ha H; Shim KS; Kim T; Lee CJ; Park JH; Kim HS; Ma JY
    BMC Complement Altern Med; 2014 Sep; 14():352. PubMed ID: 25249312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the basic helix-loop-helix transcription factor Bhlhe41 induces cell death and impairs neurite outgrowth in Neuro2a cells.
    Sun Y; Zhang H; Wang L; Li J; Jin H; Wang Z; Tian S; Qi L; Liu X
    Mol Cell Biochem; 2019 Jan; 450(1-2):167-174. PubMed ID: 29926321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.